You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Medtronic
McKinsey
Dow
Harvard Business School

Last Updated: November 30, 2020

DrugPatentWatch Database Preview

Drug Price Trends for NEOMYC-POLYM-DEXAMET EYE OINTM

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for NEOMYC-POLYM-DEXAMET EYE OINTM

Average Pharmacy Cost for NEOMYC-POLYM-DEXAMET EYE OINTM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NEOMYC-POLYM-DEXAMET EYE OINTM 61314-0631-36 3.67407 GM 2020-11-18
NEOMYC-POLYM-DEXAMET EYE OINTM 24208-0795-35 3.67407 GM 2020-11-18
NEOMYC-POLYM-DEXAMET EYE OINTM 00574-4160-35 3.67407 GM 2020-11-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Boehringer Ingelheim
McKinsey
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.